fluvoxamine

Fluvoxamine is prescribed for the treatment of obsessive-compulsive disorder, characterized by persistent bothersome thoughts and repetitive actions, as well as for social anxiety disorder, which involves an extreme fear of social interactions or performing in front of others that disrupts daily life.

Potential side effects include headaches, nausea, diarrhea, dry mouth, dizziness, increased sweating, nervousness, restlessness, fatigue, and insomnia. These symptoms often improve during the first week or two of medication use.

Individuals with a history of mania should be aware that Fluvoxamine may increase the risk of triggering manic episodes. Therefore, close monitoring by a healthcare provider is essential. For individuals with unstable epilepsy, this medication is contraindicated due to the potential for seizures.

Avoid consuming alcohol while taking Fluvoxamine, as it may lead to drowsiness, impaired cognitive function, blurred vision, or reduced muscle control.

Similar to other SSRIs, Fluvoxamine has a stimulant profile that can be potentially dangerous, with mania being its extreme manifestation. Unfortunately, this stimulant aspect may not be readily apparent in the medication’s labeling, but it is discussed in the Precautions section.

Luvox (fluvoxamine) and Lexapro (escitalopram) are both selective serotonin reuptake inhibitor (SSRI) antidepressants used in the management of depression, anxiety, and obsessive-compulsive disorders, but Luvox is additionally indicated for treating obsessive-compulsive disorders.

Possible adverse effects of Fluvoxamine encompass diminished appetite, weight loss, nervousness, anxiety, restlessness, poor concentration, tension, and decreased sexual desire or sexual problems, including difficulty maintaining an erection.

Unlike most SSRIs, which are primarily used for depression and anxiety, Fluvoxamine is specifically approved for the treatment of obsessive-compulsive disorder (OCD) and is associated with a higher likelihood of side effects, such as diarrhea and nausea, as well as an increased risk of drug interactions.

When comparing various antidepressants, it was found that Fluvoxamine had the highest risk of hair loss, while fluoxetine and paroxetine had the lowest risk.

Luvox (fluvoxamine) and Prozac (fluoxetine) are both selective serotonin reuptake inhibitor (SSRI) antidepressants used for depression and obsessive-compulsive disorders. Luvox is also indicated for social anxiety disorder.

Due to the potential for Fluvoxamine to cause weight loss or reduced appetite, children on long-term treatment should have their weight and growth monitored regularly by a healthcare professional.

Improvement in sleep, energy levels, or appetite may become noticeable within the first 1-2 weeks of taking Fluvoxamine, indicating the medication’s initial effectiveness. However, an improvement in mood and interest in activities may require 6-8 weeks to fully manifest.

Antidepressant medications include Amitriptyline, Effexor (venlafaxine), Lexapro (escitalopram), Paxil (paroxetine), Remeron (mirtazapine), and Trintellix (vortioxetine).

In the treatment of major depressive episodes, Fluvoxamine and fluoxetine exhibit similar efficacy and safety profiles. However, Fluvoxamine may have a quicker onset of action in terms of alleviating depressive symptoms and improving sleep quality.

Like other SSRIs, the most commonly reported adverse event associated with Fluvoxamine is nausea. Unlike some other medications, Fluvoxamine does not typically cause sedation, cognitive impairment, sexual dysfunction, suicidal thoughts, or withdrawal reactions.

Comparing Lexapro and Luvox, Lexapro has a higher average rating based on user reviews, with 68% reporting a positive effect and 16% noting a negative effect. Luvox, on the other hand, has a slightly lower average rating, with 7.0 out of 10 based on 137 ratings.

Fluvoxamine
Zoloft (sertraline)
Sertraline

View all 367 reviews for Fluvoxamine
View all 1923 reviews for Zoloft (sertraline)
View all 4359 reviews for Sertraline

Drug Class:
Selective serotonin reuptake inhibitors (SSRIs)

Side Effects: Not specified in the provided text.

Selective serotonin reuptake inhibitors (SSRIs) include Fluvoxamine, Zoloft (sertraline), Sertraline, Citalopram (Celexa), Escitalopram (Lexapro), Fluoxetine (Prozac), Paroxetine (Paxil), and Sertraline (Zoloft).

Fluvoxamine is a potent selective serotonin reuptake inhibitor with approximately 100-fold greater affinity for the serotonin transporter compared to the norepinephrine transporter.

In terms of weight changes associated with SSRIs, Citalopram is linked to the most weight gain, while Fluvoxamine is associated with the most weight loss among SSRIs. However, compared to other classes of antidepressants like TCAs and MAOIs, most SSRIs tend to have a relatively neutral effect on weight.

Fluvoxamine may induce agitation, irritability, or abnormal behavior in some individuals. Additionally, it could increase the risk of suicidal thoughts or exacerbate depression in children, teenagers, and young adults.

User reviews indicate that Fluvoxamine has an average rating of 5.3 out of 10 for the treatment of Anxiety and Stress. Approximately 41% of reviewers reported positive experiences, while 42% reported negative ones.

Just like the previous point, improvement in sleep, energy levels, or appetite may occur within the first 1-2 weeks of starting Fluvoxamine treatment, while mood and interest in activities may take 6-8 weeks to fully improve.

Luvox (fluvoxamine) and Zoloft (sertraline) are both selective serotonin reuptake inhibitor (SSRI) antidepressants used to treat depression and obsessive-compulsive disorders. Luvox is also indicated for social anxiety disorder.

Fluvoxamine has an average rating of 6.7 out of 10 based on user reviews, with 56% of reviewers reporting a positive effect and 24% reporting a negative effect. Zoloft, on the other hand, has an average rating of 7.2 out of 10 based on a larger number of user ratings.

Due to the potential for Fluvoxamine to cause weight loss or decreased appetite, children prescribed this medication for an extended period should have their weight and growth monitored by a healthcare professional.

The time it takes for Fluvoxamine to start working varies among individuals, but many people with OCD may not notice any improvement in their symptoms for approximately 4 to 6 weeks, and some may require 10 to 12 weeks to observe significant changes in their symptoms.

Luvox (fluvoxamine) and Lexapro (escitalopram) are both selective serotonin reuptake inhibitor (SSRI) antidepressants used for the treatment of depression and anxiety. Luvox is additionally approved for managing obsessive-compulsive disorders.

Comparing Lexapro and Luvox, Lexapro has a higher average rating, with 68% of users reporting a positive effect and 16% noting a negative effect. Luvox, in contrast, has an average rating of 7.0 out of 10 based on 137 user ratings.

Fluvoxamine increases the levels of serotonin in the brain, a neurotransmitter that regulates mood. It belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). If you have any questions about the use of this medicine, consult your healthcare provider or pharmacist.

This medication may elevate the risk of bleeding issues. Inform your doctor if you are taking other blood-thinning medications, such as aspirin, NSAIDs (e.g., diclofenac, ibuprofen, naproxen), or warfarin, as it may interact with them.

Luvox had an additional warning due to concerns about its association with violent behavior and suicidal ideation in children and teenagers. It was removed from the U.S. market in 2002 following concerns linked to the Columbine Massacre in 1999.

Fluvoxamine may lead to agitation, irritability, or unusual behaviors in certain individuals. It may also increase the risk of suicidal thoughts and exacerbate depression in children, teenagers, and young adults.

Luvox (fluvoxamine) and Zoloft (sertraline) are both selective serotonin reuptake inhibitor (SSRI) antidepressants used to treat depression and obsessive-compulsive disorders. Luvox is also indicated for social anxiety disorder (social phobia).

Only 36% of surveyed general practitioners reported that Fluvoxamine was effective, compared to approximately 60% for fluoxetine, sertraline, and paroxetine. Additionally, Fluvoxamine was associated with a higher incidence of adverse events compared to the other three SSRIs.

If your daily dose of Fluvoxamine exceeds 100 mg, your doctor may recommend splitting the dose into two administrations. For children aged 8 to 17 years, the initial dose is typically 25 mg at bedtime, with possible dose adjustments up to a maximum of 200 mg to 300 mg per day depending on age.